Busca un médico

Sarosh R. Irani, B.M.B.Ch., D.Phil.

  1. Neurologist
Solicite una Consulta

Publicaciones

  1. Binks SNM, Elliott KS, Muniz-Castrillo S, Gilbert E, Kawasaki de Araujo T, Harper AR, Brown AC, Chong AY, Band G, Peris Sempere V, Pinto AL, Costantino F, Rayner NW, Mentzer AJ, Delanty N, Rogemond V, Picard G, Handel AE, Melzer N, Titulaer MJ, Lee ST, Leypoldt F, Kuhlenbaeumer G, Honnorat J, Mignot E, Cavelleri GL, Knight JC, Irani SR. Novel risk loci in LGI1-antibody encephalitis: genome-wide association study discovery and validation cohorts. Brain. 2024 Oct 26 [Epub ahead of print]
    View PubMed
  2. Al-Diwani A, Provine NM, Murchison A, Laban R, Swann OJ, Koychev I, Sheerin F, Da Mesquita S, Heslegrave A, Zetterberg H, Klenerman P, Irani SR. Neurodegenerative fluid biomarkers are enriched in human cervical lymph nodes. Brain. 2024 Oct 21 [Epub ahead of print]
    View PubMed
  3. das Neves SP, Delivanoglou N, Ren Y, Cucuzza CS, Makuch M, Almeida F, Sanchez G, Barber MJ, Rego S, Schrader R, Faroqi AH, Thomas JL, McLean PJ, Oliveira TG, Irani SR, Piehl F, Da Mesquita S. Meningeal lymphatic function promotes oligodendrocyte survival and brain myelination. Immunity. 2024 Oct 8; 57 (10):2328-2343.e8 Epub 2024 Aug 31
    View PubMed
  4. Bennett JL, Pittock SJ, Paul F, Kim HJ, Irani SR, O'Connor KC, Patterson KR, Smith MA, Gunsior M, Mittereder N, Rees WA, Cimbora D, Cree BAC. B cell and aquaporin-4 antibody relationships with neuromyelitis optica spectrum disorder activity. Ann Clin Transl Neurol. 2024 Oct; 11 (10):2792-2798 Epub 2024 Sept 02
    View PubMed
  5. Handel A, Irani SR, Oswal A. Oculomotor Nerve Neuromyotonia: An Inflammatory Syndrome. Neurology. 2024 Sep 10; 103 (5):e209769 Epub 2024 Aug 12
    View PubMed
  6. Ritzau-Jost A, Gsell F, Sell J, Sachs S, Montanaro J, Kirmann T, Maass S, Irani SR, Werner C, Geis C, Sauer M, Shigemoto R, Hallermann S. LGI1 Autoantibodies Enhance Synaptic Transmission by Presynaptic K(v)1 Loss and Increased Action Potential Broadening. Neurol Neuroimmunol Neuroinflamm. 2024 Sep; 11 (5):e200284 Epub 2024 Aug 14
    View PubMed
  7. Upadhya M, Kirmann T, Wilson MA, Simon CM, Dhangar D, Geis C, Williams R, Woodhall G, Hallermann S, Irani SR, Wright SK. Peripherally-derived LGI1-reactive monoclonal antibodies cause epileptic seizures in vivo. Brain. 2024 Aug 1; 147 (8):2636-2642
    View PubMed
  8. Cleaver J, Dale R, Irani SR. Hunting the origin and source of NR1-directed IgGs in patients with encephalitis. Brain Behav Immun 2024 Aug; 120:554-556 Epub 2024 July 08
    View PubMed
  9. Yogeshwar SM, Muniz-Castrillo S, Sabater L, Peris-Sempere V, Mallajosyula V, Luo G, Yan H, Yu E, Zhang J, Lin L, Fagundes Bueno F, Ji X, Picard G, Rogemond V, Pinto AL, Heidbreder A, Hoftberger R, Graus F, Dalmau J, Santamaria J, Iranzo A, Schreiner B, Giannoccaro MP, Liguori R, Shimohata T, Kimura A, Ono Y, Binks S, Mariotto S, Dinoto A, Bonello M, Hartmann CJ, Tambasco N, Nigro P, Pruss H, McKeon A, Davis MM, Irani SR, Honnorat J, Gaig C, Finke C, Mignot E. HLA-DQB1*05 subtypes and not DRB1*10:01 mediates risk in anti-IgLON5 disease. Brain. 2024 Jul 5; 147 (7):2579-2592
    View PubMed
  10. Rada A, Hagemann A, Aaberg Poulsen C, Baumgartner T, Berki T, Blaabjerg M, Brenner J, Britton JW, Christiana A, Ciano-Petersen NL, Crijnen Y, Elisak M, Farina A, Friedman AR, Hayden Z, Hebert J, Holtkamp M, Hong Z, Honnorat J, Ilyas-Feldmann M, Irani SR, Kovac S, Marusic P, Muniz-Castrillo S, Ramanathan S, Smith KM, Steriade C, Strippel C, Surges R, Titulaer MJ, Uy CE, de Vries JM, Bien CG, Specht U. Risk of Seizure Recurrence Due to Autoimmune Encephalitis With NMDAR, LGI1, CASPR2, and GABA(B)R Antibodies: Implications for Return to Driving. Neurol Neuroimmunol Neuroinflamm. 2024 Jul; 11 (4):e200225 Epub 2024 June 04
    View PubMed
  11. Xiong W, Yeo T, May JTM, Demmers T, Ceronie B, Ramesh A, McGinty RN, Michael S, Torzillo E, Sen A, Anthony DC, Irani SR, Probert F. Distinct plasma metabolomic signatures differentiate autoimmune encephalitis from drug-resistant epilepsy. Ann Clin Transl Neurol. 2024 Jul; 11 (7):1897-1908 Epub 2024 June 21
    View PubMed
  12. Kelly MJ, Grant E, Murchison AG, Binks S, Ramanathan S, Michael S, Handel AE, Handunnetthi L, Uy CE, Soltys JN, Dubey D, Day GS, Lopez-Chiriboga AS, Flanagan EP, Sheerin F, Irani SR. Magnetic Resonance Imaging Characteristics of LGI1-Antibody and CASPR2-Antibody Encephalitis. JAMA Neurol. 2024 May 1; 81 (5):525-533
    View PubMed
  13. Michael BD, Dunai C, Needham EJ, Tharmaratnam K, Williams R, Huang Y, Boardman SA, Clark JJ, Sharma P, Subramaniam K, Wood GK, Collie C, Digby R, Ren A, Norton E, Leibowitz M, Ebrahimi S, Fower A, Fox H, Tato E, Ellul MA, Sunderland G, Held M, Hetherington C, Egbe FN, Palmos A, Stirrups K, Grundmann A, Chiollaz AC, Sanchez JC, Stewart JP, Griffiths M, Solomon T, Breen G, Coles AJ, Kingston N, Bradley JR, Chinnery PF, Cavanagh J, Irani SR, Vincent A, Baillie JK, Openshaw PJ, Semple MG, Taams LS, Menon DK, ISARIC4C Investigators//COVID-CNS Consortium. Author Correction: Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses. Nat Commun. 2024 Apr 4; 15 (1):2918 Epub 2024 Apr 04
    View PubMed
  14. Michael S, Varley J, Williams R, Bajorek T, Easton A, Irani SR. Criminality in patients with autoimmune encephalitis: A case series. Eur J Neurol. 2024 Apr; 31 (4):e16197 Epub 2024 Jan 08
    View PubMed
  15. Binks SNM, Veldsman M, Handel AE, Jacob S, Maddison P, Coebergh J, Michael S, Ramanathan S, Easton A, Nissen MS, Leite MI, Okai D, Blaabjerg M, Husain M, Irani SR. Fatigue predicts quality of life after leucine-rich glioma-inactivated 1-antibody encephalitis. Ann Clin Transl Neurol. 2024 Apr; 11 (4):1053-1058 Epub 2024 Feb 01
    View PubMed
  16. Handel AE, Irani SR, Leite MI. MOG-IgA as a Potential Marker of Germinal Center Activity. JAMA Neurol. 2024 Mar 1; 81 (3):297
    View PubMed
  17. Budhram A, Irani SR, Flanagan EP. Looking Beyond Syndrome-Based Criteria for Autoimmune Encephalitis-The Need for Complementary Neural Antibody-Based Diagnostic Criteria. JAMA Neurol. 2024 Mar 1; 81 (3):227-228
    View PubMed
  18. Theorell J, Harrison R, Williams R, Raybould MIJ, Zhao M, Fox H, Fower A, Miller G, Wu Z, Browne E, Mgbachi V, Sun B, Mopuri R, Li Y, Waters P, Deane CM, Handel A, Makuch M, Irani SR. Ultrahigh frequencies of peripherally matured LGI1- and CASPR2-reactive B cells characterize the cerebrospinal fluid in autoimmune encephalitis. Proc Natl Acad Sci U S A. 2024 Feb 13; 121 (7):e2311049121 Epub 2024 Feb 06
    View PubMed
  19. Peris Sempere V, Luo G, Muniz-Castrillo S, Pinto AL, Picard G, Rogemond V, Titulaer MJ, Finke C, Leypoldt F, Kuhlenbaumer G, Jones HF, Dale RC, Binks S, Irani SR, Bastiaansen AE, de Vries JM, de Bruijn MAAM, Roelen DL, Kim TJ, Chu K, Lee ST, Kanbayashi T, Pollock NR, Kichula KM, Mumme-Monheit A, Honnorat J, Norman PJ, Mignot E, GENERATE study group. HLA and KIR genetic association and NK cells in anti-NMDAR encephalitis. Front Immunol. 2024; 15:1423149 Epub 2024 July 10
    View PubMed
  20. Lee ST, Abboud H, Irani SR, Nakajima H, Piquet AL, Pittock SJ, Yeh EA, Wang J, Rajan S, Overell J, Smith J, St Lambert J, El-Khairi M, Gafarova M, Gelfand JM. Innovation and optimization in autoimmune encephalitis trials: the design and rationale for the Phase 3, randomized study of satralizumab in patients with NMDAR-IgG-antibody-positive or LGI1-IgG-antibody-positive autoimmune encephalitis (CIELO). Front Neurol. 2024; 15:1437913 Epub 2024 Aug 13
    View PubMed
  21. Michael BD, Dunai C, Needham EJ, Tharmaratnam K, Williams R, Huang Y, Boardman SA, Clark JJ, Sharma P, Subramaniam K, Wood GK, Collie C, Digby R, Ren A, Norton E, Leibowitz M, Ebrahimi S, Fower A, Fox H, Tato E, Ellul MA, Sunderland G, Held M, Hetherington C, Egbe FN, Palmos A, Stirrups K, Grundmann A, Chiollaz AC, Sanchez JC, Stewart JP, Griffiths M, Solomon T, Breen G, Coles AJ, Kingston N, Bradley JR, Chinnery PF, Cavanagh J, Irani SR, Vincent A, Baillie JK, Openshaw PJ, Semple MG, Taams LS, Menon DK, ISARIC4C Investigators//COVID-CNS Consortium. Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses. Nat Commun. 2023 Dec 22; 14 (1):8487
    View PubMed
  22. Zivelonghi C, Dinoto A, Irani SR, McKeon A, Pilotto A, Padovani A, Masciocchi S, Magni E, Mancinelli CR, Capra R, Maniscalco GT, Volonghi I, Easton A, Alberti D, Zanusso G, Monaco S, Salvagno GL, Lippi G, Ferrari S, Mariotto S. SARS-CoV-2 antibodies in inflammatory neurological conditions: a multicentre retrospective comparative study. Immunol Res. 2023 Oct; 71 (5):717-724 Epub 2023 May 12
    View PubMed
  23. Sell J, Rahmati V, Kempfer M, Irani SR, Ritzau-Jost A, Hallermann S, Geis C. Comparative Effects of Domain-Specific Human Monoclonal Antibodies Against LGI1 on Neuronal Excitability. Neurol Neuroimmunol Neuroinflamm. 2023 May; 10 (3) Epub 2023 Apr 07
    View PubMed
  24. Handel AE, Palace J, Bateman E, Waters P, Irani SR. Changes in the Rate of Leucine-Rich Glioma-Inactivated 1 Seropositivity During the COVID-19 Lockdown. JAMA Neurol. 2023 Apr 1; 80 (4):419-420
    View PubMed
  25. Flanagan EP, Geschwind MD, Lopez-Chiriboga AS, Blackburn KM, Turaga S, Binks S, Zitser J, Gelfand JM, Day GS, Dunham SR, Rodenbeck SJ, Clardy SL, Solomon AJ, Pittock SJ, McKeon A, Dubey D, Zekeridou A, Toledano M, Turner LE, Vernino S, Irani SR. Autoimmune Encephalitis Misdiagnosis in Adults. JAMA Neurol. 2023 Jan 1; 80 (1):30-39
    View PubMed
  26. Flanagan EP, Geschwind MD, Lopez-Chiriboga AS, Blackburn KM, Turaga S, Binks S, Zitser J, Gelfand JM, Day GS, Dunham SR, Rodenbeck SJ, Clardy SL, Solomon AJ, Pittock SJ, McKeon A, Dubey D, Zekeridou A, Toledano M, Turner LE, Vernino S, Irani SR. Autoimmune Encephalitis Misdiagnosis in Adults. JAMA Neurol. 2023 Jan 1; 80(1):30-39. Epub 1900 Jan 01.
    View PubMed
  27. Al-Diwani A, Theorell J, Damato V, Bull J, McGlashan N, Green E, Kienzler AK, Harrison R, Hassanali T, Campo L, Browne M, Easton A, Soleymani Majd H, Tenaka K, Iorio R, Dale RC, Harrison P, Geddes J, Quested D, Sharp D, Lee ST, Nauen DW, Makuch M, Lennox B, Fowler D, Sheerin F, Waters P, Leite MI, Handel AE, Irani SR. Cervical lymph nodes and ovarian teratomas as germinal centres in NMDA receptor-antibody encephalitis. Brain. 2022 Aug 27; 145 (8):2742-2754
    View PubMed
  28. Damato V, Theorell J, Al-Diwani A, Kienzler AK, Makuch M, Sun B, Handel A, Akdeniz D, Berretta A, Ramanathan S, Fower A, Whittam D, Gibbons E, McGlashan N, Green E, Huda S, Woodhall M, Palace J, Sheerin F, Waters P, Leite MI, Jacob A, Irani SR. Rituximab abrogates aquaporin-4-specific germinal center activity in patients with neuromyelitis optica spectrum disorders. Proc Natl Acad Sci U S A. 2022 Jun 14; 119 (24):e2121804119 Epub 2022 June 06
    View PubMed
  29. Goebel A, Andersson D, Barker C, Basu N, Bullock C, Bevan S, Bashford-Rogers RJM, Choy E, Clauw D, Dulake D, Dulake R, Flor H, Glanvill M, Helyes Z, Irani S, Kosek E, Laird J, MacFarlane G, McCullough H, Marshall A, Moots R, Perrot S, Shenker N, Sher E, Sommer C, Svensson CI, Williams A, Wood G, Dorris ER. Research Recommendations Following the Discovery of Pain Sensitizing IgG Autoantibodies in Fibromyalgia Syndrome. Pain Med. 2022 May 30; 23 (6):1084-1094
    View PubMed
  30. Peris Sempere V, Muniz-Castrillo S, Ambati A, Binks S, Pinto AL, Rogemond V, Pittock SJ, Dubey D, Geschwind MD, Gelfand JM, Dilwali S, Lee ST, Knight J, Elliott KS, Irani S, Honnorat J, Mignot E. Human Leukocyte Antigen Association Study Reveals DRB1*04:02 Effects Additional to DRB1*07:01 in Anti-LGI1 Encephalitis. Neurol Neuroimmunol Neuroinflamm. 2022 Mar; 9 (2) Epub 2022 Feb 03
    View PubMed
  31. Klar VS, Ang YS, Lockwood P, Attaallah B, Dickson S, Drew D, Kienast A, Maio MR, Plant O, Slavkova E, Toniolo S, Zambellas R, Irani SR, Husain M. Assessment of apathy in neurological patients using the Apathy Motivation Index caregiver version. J Neuropsychol. 2022 Mar; 16 (1):236-258 Epub 2021 Sept 16
    View PubMed
  32. Binks S, Uy C, Honnorat J, Irani SR. Paraneoplastic neurological syndromes: a practical approach to diagnosis and management. Pract Neurol. 2022 Feb; 22 (1):19-31 Epub 2021 Sept 11
    View PubMed
  33. Jacob S, Mazibrada G, Irani SR, Jacob A, Yudina A. The Role of Plasma Exchange in the Treatment of Refractory Autoimmune Neurological Diseases: a Narrative Review. J Neuroimmune Pharmacol. 2021 Dec; 16 (4):806-817 Epub 2021 Oct 02
    View PubMed
  34. Nosadini M, Eyre M, Molteni E, Thomas T, Irani SR, Dalmau J, Dale RC, Lim M, Anlar B, Armangue T, Benseler S, Cellucci T, Deiva K, Gallentine W, Gombolay G, Gorman MP, Hacohen Y, Jiang Y, Lim BC, Muscal E, Ndondo A, Neuteboom R, Rostasy K, Sakuma H, Sartori S, Sharma S, Tenembaum SN, Van Mater HA, Wells E, Wickstrom R, Yeshokumar AK, International NMDAR Antibody Encephalitis Consensus Group. Use and Safety of Immunotherapeutic Management of N-Methyl-d-Aspartate Receptor Antibody Encephalitis: A Meta-analysis. JAMA Neurol. 2021 Nov 1; 78 (11):1333-1344
    View PubMed
  35. Ramanathan S, Tseng M, Davies AJ, Uy CE, Paneva S, Mgbachi VC, Michael S, Varley JA, Binks S, Themistocleous AC, Fehmi J, Anziska Y, Soni A, Hofer M, Waters P, Brilot F, Dale RC, Dawes J, Rinaldi S, Bennett DL, Irani SR. Leucine-Rich Glioma-Inactivated 1 versus Contactin-Associated Protein-like 2 Antibody Neuropathic Pain: Clinical and Biological Comparisons. Ann Neurol. 2021 Oct; 90(4):683-690. Epub 2021 Aug 30.
    View PubMed
  36. Uy CE, Binks S, Irani SR. Autoimmune encephalitis: clinical spectrum and management. Pract Neurol. 2021 Oct; 21 (5):412-423 Epub 2021 June 09
    View PubMed
  37. Handunnetthi L, Knezevic B, Kasela S, Burnham KL, Milani L, Irani SR, Fang H, Knight JC. Genomic Insights into Myasthenia Gravis Identify Distinct Immunological Mechanisms in Early and Late Onset Disease. Ann Neurol. 2021 Sep; 90 (3):455-463 Epub 2021 Aug 04
    View PubMed
  38. Irani SR, Nath A, Zipp F. The neuroinflammation collection: a vision for expanding neuro-immune crosstalk in Brain. Brain. 2021 Aug 17; 144 (7):e59
    View PubMed
  39. Graus F, Vogrig A, Muñiz-Castrillo S, Antoine JG, Desestret V, Dubey D, Giometto B, Irani SR, Joubert B, Leypoldt F, McKeon A, Prüss H, Psimaras D, Thomas L, Titulaer MJ, Vedeler CA, Verschuuren JJ, Dalmau J, Honnorat J. Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes. Neurol Neuroimmunol Neuroinflamm. 2021 Jul; 8(4). Epub 2021 May 18.
    View PubMed
  40. Nosadini M, Thomas T, Eyre M, Anlar B, Armangue T, Benseler SM, Cellucci T, Deiva K, Gallentine W, Gombolay G, Gorman MP, Hacohen Y, Jiang Y, Lim BC, Muscal E, Ndondo A, Neuteboom R, Rostasy K, Sakuma H, Sharma S, Tenembaum SN, Van Mater HA, Wells E, Wickstrom R, Yeshokumar AK, Irani SR, Dalmau J, Lim M, Dale RC. International Consensus Recommendations for the Treatment of Pediatric NMDAR Antibody Encephalitis. Neurol Neuroimmunol Neuroinflamm. 2021 Jul; 8 (5) Epub 2021 July 22
    View PubMed
  41. Schanda K, Peschl P, Lerch M, Seebacher B, Mindorf S, Ritter N, Probst M, Hegen H, Di Pauli F, Wendel EM, Lechner C, Baumann M, Mariotto S, Ferrari S, Saiz A, Farrell M, Leite MIS, Irani SR, Palace J, Lutterotti A, Kumpfel T, Vukusic S, Marignier R, Waters P, Rostasy K, Berger T, Probst C, Hoftberger R, Reindl M. Differential Binding of Autoantibodies to MOG Isoforms in Inflammatory Demyelinating Diseases. Neurol Neuroimmunol Neuroinflamm. 2021 Jul; 8 (5) Epub 2021 June 15
    View PubMed
  42. Binks SNM, Veldsman M, Easton A, Leite MI, Okai D, Husain M, Irani SR. Residual Fatigue and Cognitive Deficits in Patients After Leucine-Rich Glioma-Inactivated 1 Antibody Encephalitis. JAMA Neurol. 2021 May 1; 78 (5):617-619
    View PubMed
  43. Ramanathan S, Al-Diwani A, Waters P, Irani SR. The autoantibody-mediated encephalitides: from clinical observations to molecular pathogenesis. J Neurol. 2021 May; 268 (5):1689-1707 Epub 2019 Oct 26
    View PubMed
  44. Abboud H, Probasco J, Irani SR, Ances B, Benavides DR, Bradshaw M, Christo PP, Dale RC, Fernandez-Fournier M, Flanagan EP, Gadoth A, George P, Grebenciucova E, Jammoul A, Lee ST, Li Y, Matiello M, Morse AM, Rae-Grant A, Rojas G, Rossman I, Schmitt S, Venkatesan A, Vernino S, Pittock SJ, Titulaer M, Autoimmune Encephalitis Alliance Clinicians Network. Autoimmune encephalitis: proposed recommendations for symptomatic and long-term management. J Neurol Neurosurg Psychiatry. 2021 Mar 1; 92 (8):897-907 Epub 2021 Mar 01
    View PubMed
  45. McGinty RN, Handel A, Moloney T, Ramesh A, Fower A, Torzillo E, Kramer H, Howell S, Waters P, Adcock J, Sen A, Lang B, Irani SR. Clinical features which predict neuronal surface autoantibodies in new-onset focal epilepsy: implications for immunotherapies. J Neurol Neurosurg Psychiatry. 2021 Mar; 92 (3):291-294 Epub 2020 Nov 20
    View PubMed
  46. MacKenzie G, Subramaniam S, Caldwell LJ, Fitzgerald D, Harrison NA, Hong S, Irani SR, Khandaker GM, Liston A, Miron VE, Mondelli V, Morgan BP, Pariante C, Shah DK, Taams LS, Teeling JL, Upthegrove R. Research priorities for neuroimmunology: identifying the key research questions to be addressed by 2030. Wellcome Open Res. 2021; 6:194 Epub 2021 July 29
    View PubMed
  47. Nishimura S, Kobayashi Y, Ohnishi H, Moriya K, Tsumura M, Sakata S, Mizoguchi Y, Takada H, Kato Z, Sancho-Shimizu V, Picard C, Irani SR, Ohara O, Casanova JL, Puel A, Ishikawa N, Okada S, Kobayashi M. IRAK4 Deficiency Presenting with Anti-NMDAR Encephalitis and HHV6 Reactivation. J Clin Immunol. 2021 Jan; 41 (1):125-135 Epub 2020 Oct 20
    View PubMed
  48. Varley JA, Andersson M, Grant E, Berretta A, Zandi MS, Bondet V, Duffy D, Hunt D, Piehl F, Waters P, Irani SR. Absence of Neuronal Autoantibodies in Neuropsychiatric Systemic Lupus Erythematosus. Ann Neurol. 2020 Dec; 88 (6):1244-1250 Epub 2020 Oct 06
    View PubMed
  49. Michael S, Waters P, Irani SR. Stop testing for autoantibodies to the VGKC-complex: only request LGI1 and CASPR2. Pract Neurol. 2020 Oct; 20 (5):377-384 Epub 2020 June 28
    View PubMed
  50. Sun B, Ramberger M, O'Connor KC, Bashford-Rogers RJM, Irani SR. The B cell immunobiology that underlies CNS autoantibody-mediated diseases. Nat Rev Neurol. 2020 Sep; 16 (9):481-492 Epub 2020 July 28
    View PubMed
  51. Uribe-San-Martin R, Ciampi E, Santibanez R, Irani SR, Marquez A, Cruz JP, Soler B, Miranda MC, Henriquez M, Carcamo C. LGI1-antibody associated epilepsy successfully treated in the outpatient setting. J Neuroimmunol. 2020 Aug 15; 345:577268 Epub 2020 May 23
    View PubMed
  52. Steriade C, Britton J, Dale RC, Gadoth A, Irani SR, Linnoila J, McKeon A, Shao XQ, Venegas V, Bien CG. Acute symptomatic seizures secondary to autoimmune encephalitis and autoimmune-associated epilepsy: Conceptual definitions. Epilepsia. 2020 Jul; 61 (7):1341-1351 Epub 2020 June 16
    View PubMed
  53. Ramberger M, Berretta A, Tan JMM, Sun B, Michael S, Yeo T, Theorell J, Bashford-Rogers R, Paneva S, O'Dowd V, Dedi N, Topia S, Griffin R, Ramirez-Franco J, El Far O, Baulac S, Leite MI, Sen A, Jeans A, McMillan D, Marshall D, Anthony D, Lightwood D, Waters P, Irani SR. Distinctive binding properties of human monoclonal LGI1 autoantibodies determine pathogenic mechanisms. Brain. 2020 Jun 1; 143 (6):1731-1745
    View PubMed
  54. Kim Y, Hyun JW, Woodhall MR, Oh YM, Lee JE, Jung JY, Kim SY, Lee MY, Kim SH, Kim W, Irani SR, Waters P, Choi K, Kim HJ. Refining cell-based assay to detect MOG-IgG in patients with central nervous system inflammatory diseases. Mult Scler Relat Disord. 2020 May; 40:101939 Epub 2020 Jan 09
    View PubMed
  55. Argyropoulos GPD, Moore L, Loane C, Roca-Fernandez A, Lage-Martinez C, Gurau O, Irani SR, Zeman A, Butler CR. Pathologic tearfulness after limbic encephalitis: A novel disorder and its neural basis. Neurology. 2020 Mar 24; 94 (12):e1320-e1335 Epub 2020 Jan 24
    View PubMed
  56. Reindl M, Schanda K, Woodhall M, Tea F, Ramanathan S, Sagen J, Fryer JP, Mills J, Teegen B, Mindorf S, Ritter N, Krummrei U, Stocker W, Eggert J, Flanagan EP, Ramberger M, Hegen H, Rostasy K, Berger T, Leite MI, Palace J, Irani SR, Dale RC, Probst C, Probst M, Brilot F, Pittock SJ, Waters P. International multicenter examination of MOG antibody assays. Neurol Neuroimmunol Neuroinflamm. 2020 Mar 5; 7 (2) Epub 2020 Feb 05
    View PubMed
  57. Lehmann-Horn K, Irani SR, Wang S, Palanichamy A, Jahn S, Greenfield AL, Dandekar R, Lepennetier G, Michael S, Gelfand JM, Geschwind MD, Wilson MR, Zamvil SS, von Budingen HC. Intrathecal B-cell activation in LGI1 antibody encephalitis. Neurol Neuroimmunol Neuroinflamm. 2020 Mar; 7 (2) Epub 2020 Feb 06
    View PubMed
  58. Xu M, Bennett DLH, Querol LA, Wu LJ, Irani SR, Watson JC, Pittock SJ, Klein CJ. Pain and the immune system: emerging concepts of IgG-mediated autoimmune pain and immunotherapies. J Neurol Neurosurg Psychiatry. 2020 Feb; 91(2):177-188. Epub 2018 Sep 17.
    View PubMed
  59. Dubey D, Britton J, McKeon A, Gadoth A, Zekeridou A, Lopez Chiriboga SA, Devine M, Cerhan JH, Dunlay K, Sagen J, Ramberger M, Waters P, Irani SR, Pittock SJ. Randomized Placebo-Controlled Trial of Intravenous Immunoglobulin in Autoimmune LGI1/CASPR2 Epilepsy. Ann Neurol. 2020 Feb; 87 (2):313-323 Epub 2019 Dec 14
    View PubMed
  60. Miller TD, Chong TT, Aimola Davies AM, Johnson MR, Irani SR, Husain M, Ng TW, Jacob S, Maddison P, Kennard C, Gowland PA, Rosenthal CR. Human hippocampal CA3 damage disrupts both recent and remote episodic memories. Elife. 2020 Jan 24; 9
    View PubMed
  61. Chen H, Wu J, Irani SR. Distinctive Magnetic Resonance Imaging Findings in IgLON5 Antibody Disease. JAMA Neurol. 2020 Jan 1; 77 (1):125-126
    View PubMed
  62. Waters P, Fadda G, Woodhall M, O'Mahony J, Brown RA, Castro DA, Longoni G, Irani SR, Sun B, Yeh EA, Marrie RA, Arnold DL, Banwell B, Bar-Or A, Canadian Pediatric Demyelinating Disease Network. Serial Anti-Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children With Demyelinating Syndromes. JAMA Neurol. 2020 Jan 1; 77 (1):82-93
    View PubMed
  63. Williams D, McGlasson S, Irani SR, Duffy D, Crow Y, Hunt D; Scottish NMOSD study group. Neuromyelitis optica in patients with increased interferon alpha concentrations Lancet Neurology. 2020; 19(1).
  64. Romoli M, Krashia P, Sen A, Franciotta D, Gastaldi M, Nobili A, Mancini A, Nardi Cesarini E, Nigro P, Tambasco N, Mercuri NB, Parnetti L, Di Filippo M, D'Amelio M, Irani SR, Costa C, Calabresi P. Hippocampal epileptogenesis in autoimmune encephalitis. Ann Clin Transl Neurol. 2019 Nov; 6 (11):2261-2269 Epub 2019 Oct 15
    View PubMed
  65. Crisp SJ, Dixon CL, Jacobson L, Chabrol E, Irani SR, Leite MI, Leschziner G, Slaght SJ, Vincent A, Kullmann DM. Glycine receptor autoantibodies disrupt inhibitory neurotransmission. Brain. 2019 Nov 1; 142 (11):3398-3410
    View PubMed
  66. Loane C, Argyropoulos GPD, Roca-Fernandez A, Lage C, Sheerin F, Ahmed S, Zamboni G, Mackay C, Irani SR, Butler CR. Hippocampal network abnormalities explain amnesia after VGKCC-Ab related autoimmune limbic encephalitis. J Neurol Neurosurg Psychiatry. 2019 Sep; 90 (9):965-974 Epub 2019 May 09
    View PubMed
  67. Argyropoulos GP, Loane C, Roca-Fernandez A, Lage-Martinez C, Gurau O, Irani SR, Butler CR. Network-wide abnormalities explain memory variability in hippocampal amnesia. Elife. 2019 Jul 8; 8 Epub 2019 July 08
    View PubMed
  68. Gastaldi M, De Rosa A, Maestri M, Zardini E, Scaranzin S, Guida M, Borrelli P, Ferraro OE, Lampasona V, Furlan R, Irani SR, Waters P, Lang B, Vincent A, Marchioni E, Ricciardi R, Franciotta D. Acquired neuromyotonia in thymoma-associated myasthenia gravis: a clinical and serological study. Eur J Neurol. 2019 Jul; 26 (7):992-999 Epub 2019 Mar 25
    View PubMed
  69. Takata K, Stathopoulos P, Cao M, Mane-Damas M, Fichtner ML, Benotti ES, Jacobson L, Waters P, Irani SR, Martinez-Martinez P, Beeson D, Losen M, Vincent A, Nowak RJ, O'Connor KC. Characterization of pathogenic monoclonal autoantibodies derived from muscle-specific kinase myasthenia gravis patients. JCI Insight. 2019 Jun 20; 4 (12) Epub 2019 June 20
    View PubMed
  70. Hyun JW, Huh SY, Shin HJ, Woodhall M, Kim SH, Irani SR, Lee SH, Waters P, Kim HJ. Evaluation of brain lesion distribution criteria at disease onset in differentiating MS from NMOSD and MOG-IgG-associated encephalomyelitis. Mult Scler. 2019 Apr; 25 (4):585-590 Epub 2018 Mar 07
    View PubMed
  71. Waters PJ, Komorowski L, Woodhall M, Lederer S, Majed M, Fryer J, Mills J, Flanagan EP, Irani SR, Kunchok AC, McKeon A, Pittock SJ. A multicenter comparison of MOG-IgG cell-based assays. Neurology. 2019 Mar 12; 92(11):e1250-e1255. Epub 2019 Feb 06.
    View PubMed
  72. Al-Diwani A, Handel A, Townsend L, Pollak T, Leite MI, Harrison PJ, Lennox BR, Okai D, Manohar SG, Irani SR. The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data. Lancet Psychiatry. 2019 Mar; 6 (3):235-246 Epub 2019 Feb 11
    View PubMed
  73. Savage SA, Irani SR, Leite MI, Zeman AZ. NMDA receptor antibody encephalitis presenting as Transient Epileptic Amnesia. J Neuroimmunol. 2019 Feb 15; 327:41-43 Epub 2019 Jan 22
    View PubMed
  74. Vincent A, Pettingill P, Pettingill R, Lang B, Birch R, Waters P, Irani SR, Buckley C, Watanabe O, Arimura K, Kiernan MC. Association of Leucine-Rich Glioma Inactivated Protein 1, Contactin-Associated Protein 2, and Contactin 2 Antibodies With Clinical Features and Patient-Reported Pain in Acquired Neuromyotonia. JAMA Neurol. 2018 Dec 1; 75 (12):1519-1527
    View PubMed
  75. Handel AE, Irani SR, Hollander GA. The role of thymic tolerance in CNS autoimmune disease. Nat Rev Neurol. 2018 Dec; 14 (12):723-734
    View PubMed
  76. Swayne A, Tjoa L, Broadley S, Dionisio S, Gillis D, Jacobson L, Woodhall MR, McNabb A, Schweitzer D, Tsang B, Vincent A, Irani SR, Wong R, Waters P, Blum S. Antiglycine receptor antibody related disease: a case series and literature review. Eur J Neurol. 2018 Oct; 25 (10):1290-1298 Epub 2018 July 21
    View PubMed
  77. Jang Y, Lee ST, Bae JY, Kim TJ, Jun JS, Moon J, Jung KH, Park KI, Irani SR, Chu K, Lee SK. LGI1 expression and human brain asymmetry: insights from patients with LGI1-antibody encephalitis. J Neuroinflammation. 2018 Sep 25; 15 (1):279 Epub 2018 Sept 25
    View PubMed
  78. Kinsella JA, Irani SR, Hollingsworth R, O'Shaughnessy D, Kane P, Foster M, Schott JM, Lunn MP. Use of intravenous immunoglobulin for the treatment of autoimmune encephalitis: audit of the NHS experience. JRSM Open. 2018 Sep; 9 (9):2054270418793021 Epub 2018 Sept 03
    View PubMed
  79. Damato V, Balint B, Kienzler AK, Irani SR. The clinical features, underlying immunology, and treatment of autoantibody-mediated movement disorders. Mov Disord. 2018 Sep; 33 (9):1376-1389 Epub 2018 Sept 14
    View PubMed
  80. Berridge G, Menassa DA, Moloney T, Waters PJ, Welding I, Thomsen S, Zuberi S, Fischer R, Aricescu AR, Pike M, Dale RC, Kessler B, Vincent A, Lim M, Irani SR, Lang B. Glutamate receptor delta2 serum antibodies in pediatric opsoclonus myoclonus ataxia syndrome. Neurology. 2018 Aug 21; 91 (8):e714-e723 Epub 2018 July 25
    View PubMed
  81. Binks S, Varley J, Lee W, Makuch M, Elliott K, Gelfand JM, Jacob S, Leite MI, Maddison P, Chen M, Geschwind MD, Grant E, Sen A, Waters P, McCormack M, Cavalleri GL, Barnardo M, Knight JC, Irani SR. Distinct HLA associations of LGI1 and CASPR2-antibody diseases. Brain. 2018 Aug 1; 141 (8):2263-2271
    View PubMed
  82. Symmonds M, Moran CH, Leite MI, Buckley C, Irani SR, Stephan KE, Friston KJ, Moran RJ. Ion channels in EEG: isolating channel dysfunction in NMDA receptor antibody encephalitis. Brain. 2018 Jun 1; 141 (6):1691-1702
    View PubMed
  83. Binks SNM, Klein CJ, Waters P, Pittock SJ, Irani SR. LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes. J Neurol Neurosurg Psychiatry. 2018 May; 89(5):526-534. Epub 2017 Oct 21.
    View PubMed
  84. Wilson R, Menassa DA, Davies AJ, Michael S, Hester J, Kuker W, Collins GP, Cossins J, Beeson D, Steven N, Maddison P, Rinaldi S, Jacob S, Irani SR. Seronegative antibody-mediated neurology after immune checkpoint inhibitors. Ann Clin Transl Neurol. 2018 May; 5 (5):640-645 Epub 2018 Mar 25
    View PubMed
  85. Wilson R, Makuch M, Kienzler AK, Varley J, Taylor J, Woodhall M, Palace J, Leite MI, Waters P, Irani SR. Condition-dependent generation of aquaporin-4 antibodies from circulating B cells in neuromyelitis optica. Brain. 2018 Apr 1; 141 (4):1063-1074
    View PubMed
  86. Varley J, Taylor J, Irani SR. Autoantibody-mediated diseases of the CNS: Structure, dysfunction and therapy. Neuropharmacology. 2018 Apr; 132:71-82 Epub 2017 May 03
    View PubMed
  87. Makuch M, Wilson R, Al-Diwani A, Varley J, Kienzler AK, Taylor J, Berretta A, Fowler D, Lennox B, Leite MI, Waters P, Irani SR. N-methyl-D-aspartate receptor antibody production from germinal center reactions: Therapeutic implications. Ann Neurol. 2018 Mar; 83 (3):553-561
    View PubMed
  88. Thompson J, Bi M, Murchison AG, Makuch M, Bien CG, Chu K, Farooque P, Gelfand JM, Geschwind MD, Hirsch LJ, Somerville E, Lang B, Vincent A, Leite MI, Waters P, Irani SR, Faciobrachial Dystonic Seizures Study Group. The importance of early immunotherapy in patients with faciobrachial dystonic seizures. Brain. 2018 Feb 1; 141 (2):348-356
    View PubMed
  89. Nantes JC, Thomas AG, Voets NL, Best JG, Rosenthal CR, Al-Diwani A, Irani SR, Stagg CJ. Hippocampal Functional Dynamics Are Clinically Implicated in Autoimmune Encephalitis With Faciobrachial Dystonic Seizures. Front Neurol. 2018; 9:736 Epub 2018 Sept 04
    View PubMed
  90. Balint B, Vincent A, Meinck HM, Irani SR, Bhatia KP. Movement disorders with neuronal antibodies: syndromic approach, genetic parallels and pathophysiology. Brain. 2018 Jan 1; 141 (1):13-36
    View PubMed
  91. Al-Diwani AAJ, Pollak TA, Irani SR, Lennox BR. Psychosis: an autoimmune disease? Immunology. 2017 Nov; 152 (3):388-401 Epub 2017 Aug 03
    View PubMed
  92. Hyun JW, Woodhall MR, Kim SH, Jeong IH, Kong B, Kim G, Kim Y, Park MS, Irani SR, Waters P, Kim HJ. Longitudinal analysis of myelin oligodendrocyte glycoprotein antibodies in CNS inflammatory diseases. J Neurol Neurosurg Psychiatry. 2017 Oct; 88 (10):811-817 Epub 2017 July 06
    View PubMed
  93. Nibber A, Mann EO, Pettingill P, Waters P, Irani SR, Kullmann DM, Vincent A, Lang B. Pathogenic potential of antibodies to the GABA(B) receptor. Epilepsia Open. 2017 Sep; 2 (3):355-359 Epub 2017 July 19
    View PubMed
  94. Aurangzeb S, Symmonds M, Knight RK, Kennett R, Wehner T, Irani SR. LGI1-antibody encephalitis is characterised by frequent, multifocal clinical and subclinical seizures. Seizure. 2017 Aug; 50:14-17 Epub 2017 May 30
    View PubMed
  95. Miller TD, Chong TT, Aimola Davies AM, Ng TWC, Johnson MR, Irani SR, Vincent A, Husain M, Jacob S, Maddison P, Kennard C, Gowland PA, Rosenthal CR. Focal CA3 hippocampal subfield atrophy following LGI1 VGKC-complex antibody limbic encephalitis. Brain. 2017 May 1; 140 (5):1212-1219
    View PubMed
  96. Lang B, Makuch M, Moloney T, Dettmann I, Mindorf S, Probst C, Stoecker W, Buckley C, Newton CR, Leite MI, Maddison P, Komorowski L, Adcock J, Vincent A, Waters P, Irani SR. Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies. J Neurol Neurosurg Psychiatry. 2017 Apr; 88 (4):353-361 Epub 2017 Jan 23
    View PubMed
  97. Bakpa OD, Reuber M, Irani SR. Antibody-associated epilepsies: Clinical features, evidence for immunotherapies and future research questions. Seizure. 2016 Oct; 41:26-41 Epub 2016 July 15
    View PubMed
  98. Amini A, Lang B, Heaney D, Irani SR. Multiple sequential antibody-associated syndromes with a recurrent mutated neuroblastoma. Neurology. 2016 Aug 9; 87 (6):634-6 Epub 2016 July 06
    View PubMed
  99. Webb AJ, Ingale H, Irani SR, Hu MT. Acute variegate porphyria presenting with reversible cerebral vasoconstriction. Clin Neurol Neurosurg. 2016 Jul; 146:102-4 Epub 2016 May 06
    View PubMed
  100. Pollak TA, Beck K, Irani SR, Howes OD, David AS, McGuire PK. Autoantibodies to central nervous system neuronal surface antigens: psychiatric symptoms and psychopharmacological implications. Psychopharmacology (Berl). 2016 May; 233 (9):1605-21 Epub 2015 Dec 14
    View PubMed
  101. Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, Cortese I, Dale RC, Gelfand JM, Geschwind M, Glaser CA, Honnorat J, Hoftberger R, Iizuka T, Irani SR, Lancaster E, Leypoldt F, Pruss H, Rae-Grant A, Reindl M, Rosenfeld MR, Rostasy K, Saiz A, Venkatesan A, Vincent A, Wandinger KP, Waters P, Dalmau J. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016 Apr; 15 (4):391-404 Epub 2016 Feb 20
    View PubMed
  102. Savard M, Irani SR, Guillemette A, Gosselin-Lefebvre S, Geschwind M, Jansen GH, Gould PV, Laforce R Jr. Creutzfeldt-Jakob Disease-Like Periodic Sharp Wave Complexes in Voltage-Gated Potassium Channel-Complex Antibodies Encephalitis: A Case Report. J Clin Neurophysiol. 2016 Feb; 33 (1):e1-4
    View PubMed
  103. Varley JA, Irani SR. Treating seizures and preventing amnesia in LGI1-antibody encephalitis: A new MRI signature? Neurol Neuroimmunol Neuroinflamm. 2015 Dec; 2 (6):e182 Epub 2015 Nov 24
    View PubMed
  104. Pettingill P, Kramer HB, Coebergh JA, Pettingill R, Maxwell S, Nibber A, Malaspina A, Jacob A, Irani SR, Buckley C, Beeson D, Lang B, Waters P, Vincent A. Antibodies to GABAA receptor alpha1 and gamma2 subunits: clinical and serologic characterization. Neurology. 2015 Mar 24; 84 (12):1233-41 Epub 2015 Jan 30
    View PubMed
  105. Irani SR, Lehmann-Horn K, Geschwind M, Wang S, Vincent A, von Budingen HC. The active intrathecal B-cell response in LGI1-antibody encephalitis. Lancet. 2015 Feb 26; 385 Suppl 1:S46
    View PubMed
  106. Varley J, Vincent A, Irani SR. Clinical and experimental studies of potentially pathogenic brain-directed autoantibodies: current knowledge and future directions. J Neurol. 2015; 262 (4):1081-95 Epub 2014 Dec 10
    View PubMed
  107. Naasan G, Irani SR, Bettcher BM, Geschwind MD, Gelfand JM. Episodic bradycardia as neurocardiac prodrome to voltage-gated potassium channel complex/leucine-rich, glioma inactivated 1 antibody encephalitis. JAMA Neurol. 2014 Oct; 71 (10):1300-4
    View PubMed
  108. Bettcher BM, Gelfand JM, Irani SR, Neuhaus J, Forner S, Hess CP, Geschwind MD. More than memory impairment in voltage-gated potassium channel complex encephalopathy. Eur J Neurol. 2014 Oct; 21 (10):1301-10 Epub 2014 July 01
    View PubMed
  109. Irani SR, Gelfand JM, Al-Diwani A, Vincent A. Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms. Ann Neurol. 2014 Aug; 76 (2):168-84 Epub 2014 July 10
    View PubMed
  110. Irani SR, Gelfand JM, Bettcher BM, Singhal NS, Geschwind MD. Effect of rituximab in patients with leucine-rich, glioma-inactivated 1 antibody-associated encephalopathy. JAMA Neurol. 2014 Jul 1; 71 (7):896-900
    View PubMed
  111. Hacohen Y, Absoud M, Hemingway C, Jacobson L, Lin JP, Pike M, Pullaperuma S, Siddiqui A, Wassmer E, Waters P, Irani SR, Buckley C, Vincent A, Lim M. NMDA receptor antibodies associated with distinct white matter syndromes. Neurol Neuroimmunol Neuroinflamm. 2014 Jun; 1 (1):e2 Epub 2014 Apr 24
    View PubMed
  112. Irani SR, Stagg CJ, Schott JM, Rosenthal CR, Schneider SA, Pettingill P, Pettingill R, Waters P, Thomas A, Voets NL, Cardoso MJ, Cash DM, Manning EN, Lang B, Smith SJ, Vincent A, Johnson MR. Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype. Brain. 2013 Oct; 136 (Pt 10):3151-62 Epub 2013 Sept 06
    View PubMed
  113. Irani SR, Vincent A, Jacobson L, Logsdail S, Butterworth RJ. Organic neuropsychiatry: a treatable cause of suicidal behaviour. Pract Neurol. 2013 Feb; 13 (1):44-8
    View PubMed
  114. Morales-Briceno H, Rodriguez-Violante M, Cervantes-Arriaga A, Irani SR, Lees AJ, Silveira-Moriyama L. Opsoclonus myoclonus syndrome associated with GQ1b antibodies. Mov Disord. 2012 Nov; 27 (13):1615-6
    View PubMed
  115. Al-Diwani A, Butterworth RJ, Nibber A, Lang B, Vincent A, Irani SR. Acute onset of focal seizures, psychiatric features and confusion: a case of autoimmune encephalitis? BMJ Case Rep. 2012 Oct 30; 2012
    View PubMed
  116. Irani SR, Pettingill P, Kleopa KA, Schiza N, Waters P, Mazia C, Zuliani L, Watanabe O, Lang B, Buckley C, Vincent A. Morvan syndrome: clinical and serological observations in 29 cases. Ann Neurol. 2012 Aug; 72 (2):241-55 Epub 2012 Apr 04
    View PubMed
  117. Tofaris GK, Irani SR, Cheeran BJ, Baker IW, Cader ZM, Vincent A. Immunotherapy-responsive chorea as the presenting feature of LGI1-antibody encephalitis. Neurology. 2012 Jul 10; 79 (2):195-6 Epub 2012 June 27
    View PubMed
  118. Vincent A, Irani SR, Lang B. Potentially pathogenic autoantibodies associated with epilepsy and encephalitis in children and adults. Epilepsia. 2011 Oct; 52 Suppl 8:8-11
    View PubMed
  119. Turner MR, Irani SR, Leite MI, Nithi K, Vincent A, Ansorge O. Progressive encephalomyelitis with rigidity and myoclonus: glycine and NMDA receptor antibodies. Neurology. 2011 Aug 2; 77 (5):439-43 Epub 2011 July 20
    View PubMed
  120. Vincent A, Bien CG, Irani SR, Waters P. Autoantibodies associated with diseases of the CNS: new developments and future challenges. Lancet Neurol. 2011 Aug; 10 (8):759-72
    View PubMed
  121. Irani SR, Vincent A. NMDA receptor antibody encephalitis. Curr Neurol Neurosci Rep. 2011 Jun; 11 (3):298-304
    View PubMed
  122. Irani SR, Michell AW, Lang B, Pettingill P, Waters P, Johnson MR, Schott JM, Armstrong RJ, S Zagami A, Bleasel A, Somerville ER, Smith SM, Vincent A. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol. 2011 May; 69 (5):892-900 Epub 2011 Mar 17
    View PubMed
  123. Irani SR, Vincent A. Autoimmune encephalitis -- new awareness, challenging questions. Discov Med. 2011 May; 11 (60):449-58
    View PubMed
  124. Irani SR, Bien CG, Lang B. Autoimmune epilepsies. Curr Opin Neurol. 2011 Apr; 24 (2):146-53
    View PubMed
  125. Granerod J, Ambrose HE, Davies NW, Clewley JP, Walsh AL, Morgan D, Cunningham R, Zuckerman M, Mutton KJ, Solomon T, Ward KN, Lunn MP, Irani SR, Vincent A, Brown DW, Crowcroft NS, UK Health Protection Agency (HPA) Aetiology of Encephalitis Study Group. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis. 2010 Dec; 10 (12):835-44 Epub 2010 Oct 15
    View PubMed
  126. Vincent A, Irani SR. Caspr2 antibodies in patients with thymomas. J Thorac Oncol. 2010 Oct; 5 (10 Suppl 4):S277-80
    View PubMed
  127. Irani SR, Alexander S, Waters P, Kleopa KA, Pettingill P, Zuliani L, Peles E, Buckley C, Lang B, Vincent A. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain. 2010 Sep; 133 (9):2734-48 Epub 2010 July 27
    View PubMed
  128. Irani SR, Bera K, Waters P, Zuliani L, Maxwell S, Zandi MS, Friese MA, Galea I, Kullmann DM, Beeson D, Lang B, Bien CG, Vincent A. N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain. 2010 Jun; 133 (Pt 6):1655-67
    View PubMed
  129. Vincent A, Irani SR, Lang B. The growing recognition of immunotherapy-responsive seizure disorders with autoantibodies to specific neuronal proteins. Curr Opin Neurol. 2010 Apr; 23 (2):144-50
    View PubMed
  130. Davies G, Irani SR, Coltart C, Ingle G, Amin Y, Taylor C, Radcliffe J, Hirsch NP, Howard RS, Vincent A, Kullmann DM. Anti-N-methyl-D-aspartate receptor antibodies: a potentially treatable cause of encephalitis in the intensive care unit. Crit Care Med. 2010 Feb; 38 (2):679-82
    View PubMed
  131. Biancheri R, Pessagno A, Baglietto MG, Irani SR, Rossi A, Giribaldi G, Badenier MM, Vincent A, Veneselli E. Anti-N-methyl-D-aspartate-receptor encephalitis in a four-year-old girl. J Pediatr. 2010 Feb; 156 (2):332-4
    View PubMed
  132. Zandi MS, Irani SR, Follows G, Moody AM, Molyneux P, Vincent A. Limbic encephalitis associated with antibodies to the NMDA receptor in Hodgkin lymphoma. Neurology. 2009 Dec 8; 73 (23):2039-40
    View PubMed
  133. Soni A, Irani SR, Lang B, Taghipour K, Mann R, Vincent A, Collins D. Immunotherapy: responsive autoimmune encephalopathy associated with bullous pemphigoid. J Neurol Neurosurg Psychiatry 2009 Dec; 80 (12):1412-3
    View PubMed
  134. Dale RC, Irani SR, Brilot F, Pillai S, Webster R, Gill D, Lang B, Vincent A. N-methyl-D-aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica. Ann Neurol. 2009 Nov; 66 (5):704-9
    View PubMed
  135. Labate A, Irani SR, Vincent A, Gambardella A, Piane EL, Cianci V, Aguglia U. Anti-NMDA receptor encephalitis: a video case report. Epileptic Disord. 2009 Sep; 11 (3):267-9 Epub 2009 Aug 28
    View PubMed
  136. Irani SR, Buckley C, Vincent A, Cockerell OC, Rudge P, Johnson MR, Smith S. Immunotherapy-responsive seizure-like episodes with potassium channel antibodies. Neurology. 2008 Nov 11; 71 (20):1647-8 Epub 2008 Sept 24
    View PubMed
  137. Irani S, Lang B. Autoantibody-mediated disorders of the central nervous system. Autoimmunity. 2008 Feb; 41 (1):55-65
    View PubMed
  138. Jacob S, Irani SR, Rajabally YA, Grubneac A, Walters RJ, Yazaki M, Clover L, Vincent A. Hypothermia in VGKC antibody-associated limbic encephalitis. J Neurol Neurosurg Psychiatry. 2008 Feb; 79 (2):202-4
    View PubMed
  139. Irani SR, Mathias CJ, Orrell RW. Pure autonomic failure followed by amyotrophy. Neurology. 2007 Mar 6; 68 (10):792-3
    View PubMed
  140. Irani SR. A novel neurological mechanism to explain the adverse effect of depression on coronary artery disease. Med Hypotheses. 2005; 64 (2):284-7
    View PubMed
  141. Hogervorst E, Bandelow S, Combrinck M, Irani SR, Smith AD. The validity and reliability of 6 sets of clinical criteria to classify Alzheimer's disease and vascular dementia in cases confirmed post-mortem: added value of a decision tree approach. Dement Geriatr Cogn Disord. 2003; 16 (3):170-80
    View PubMed
PST-20554732